osiris acquired: significan new and early $'s

Ok..... wow!
This is massive. Seems the perfect fit. A very smart stategic acquisition. Earlier revenues, synergies, commercialisation experience brought on board, broadening of existing pipeline, extension into Japan.... the list goes on.......


I think this is the price trigger initially.....
"Significant new and early potential revenue stream with the acquisition of
Prochymal®, the world’s first approved stem cell therapeutic and the only stem
cell therapeutic designated by the United States Food and Drug Administration
(FDA) as both an Orphan Drug and Fast Track product.